BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12044572)

  • 1. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions.
    Stamatialis DF; Rolevink HH; Koops GH
    J Control Release; 2002 Jun; 81(3):335-45. PubMed ID: 12044572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of timolol through artificial membranes and pig stratum corneum.
    Stamatialis DF; Rolevink HH; Koops GH
    J Pharm Sci; 2003 May; 92(5):1037-9. PubMed ID: 12712423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
    Stamatialis DF; Rolevink HH; Gironès M; Nymeijer DC; Koops GH
    Curr Drug Deliv; 2004 Oct; 1(4):313-9. PubMed ID: 16305393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive and iontophoretic controlled delivery of salmon calcitonin through artificial membranes.
    Stamatialis DF; Rolevink HH; Koops GH
    Curr Drug Deliv; 2004 Apr; 1(2):137-43. PubMed ID: 16305379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species.
    Kanikkannan N; Singh J; Ramarao P
    J Control Release; 2001 Mar; 71(1):99-105. PubMed ID: 11245911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
    Fatouros DG; Bouwstra JA
    J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal iontophoretic delivery of timolol maleate in albino rabbits.
    Kanikkannan N; Singh J; Ramarao P
    Int J Pharm; 2000 Mar; 197(1-2):69-76. PubMed ID: 10704794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic transport across a multiple membrane system.
    Molokhia SA; Zhang Y; Higuchi WI; Li SK
    J Pharm Sci; 2008 Jan; 97(1):490-505. PubMed ID: 17990310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude.
    Yan G; Xu Q; Anissimov YG; Hao J; Higuchi WI; Li SK
    Pharm Res; 2008 Mar; 25(3):616-24. PubMed ID: 17703345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro iontophoretic transport of ketorolac: synthetic membrane as a barrier.
    Tiwari SB; Udupa N
    Drug Deliv; 2003; 10(3):161-8. PubMed ID: 12944136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-scleral iontophoretic delivery of low molecular weight therapeutics.
    Güngör S; Delgado-Charro MB; Ruiz-Perez B; Schubert W; Isom P; Moslemy P; Patane MA; Guy RH
    J Control Release; 2010 Oct; 147(2):225-31. PubMed ID: 20655965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
    Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
    J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic aspects of iontophoresis in human epidermal membrane.
    Higuchi WI; Li SK; Ghanem AH; Zhu H; Song Y
    J Control Release; 1999 Nov; 62(1-2):13-23. PubMed ID: 10518630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
    Soni S; Dixit VK
    Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
    [No Abstract]   [Full Text] [Related]  

  • 18. Transdermal delivery of timolol by electroporation through human skin.
    Denet AR; Préat V
    J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced transdermal delivery of 5-aminolevulinic acid and a dipeptide by iontophoresis.
    Krishnan G; Roberts MS; Grice J; Anissimov YG; Benson HA
    Biopolymers; 2011; 96(2):166-71. PubMed ID: 20665477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
    Nugroho AK; Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.